The Opioid Epidemic and HIV: The Indiana HIV/HCV Outbreak: Implications for Prevention
| Overview / Abstract: |
Learning Objectives Describe the key demographic changes in persons at risk for hepatitis C virus (HCV) and HIV infection in the United States Identify 3 risk factors associated with increased risk for vulnerability to new HCV or HIV infection among persons who inject drugs Identify 3 effective interventions to reduce the risk of HCV and HIV infections among persons who inject drugs The content for this activity is drawn from the 11th Annual American Conference for the Treatment of HIV (ACTHIV 2018). |
|
Expiration |
Sep 15, 2018 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Social Work CE |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
0.5 |
|
Accreditation |
ACCME, ANCC |
|
Presenters / Authors / Faculty |
John T. Brooks, MD, Senior Medical Advisor to the Division of HIV/AIDS Prevention at the Center for Disease Control and Prevention. |
|
Activity Specialities / Related Topics |
Family Medicine, HIV / AIDS, Infectious Disease, Internal Medicine, OB/GYN / Women's Health, Pharmacology, Primary Care, Public Health / Community Health, STD's / Sexually Transmitted Disease, Substance Abuse / Dependence |
|
Sponsors / Supporters / Grant Providers |
he 11th Annual American Conference for the Treatment of HIV (ACTHIV) was held April 20-22, 2017 in Dallas, TX. The Conference was supported by funding from the Clinical Education Initiative, New York State Department of Health, AIDS Institute; and from the HIV Medicine Association (HIVMA). The conference and this web archive were supported by educational grants from Bristol-Myers Squibb; Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare. |
|
Keywords / Search Terms |
American Academy of CME HIV, AIDS, ACTHIV, American Conference for the Treatment of HIV, Infectious Disease, CME, CNE, CE, opioids Free CE CME |
|